Adding pembrolizumab before and after surgery reduced recurrence and improved response in patients with locally advanced head and neck squamous cell carcinoma, according to new phase III trial data.

Discover a recent study that has provided crucial new insights into the treatment of upper tract urothelial carcinoma.